IceCure Medical Ltd. Ordinary Shares
Market Cap
11M
Short interest (May 15)
1.6%
Net Short (Jun 03 ): -0.6%
Borrow Fee
7.77%
↓ 11.2%
Available Shares
1M
↓ 20.9%
Price Chart
Company Overview
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.